I've seen statistics comparing AC+T and TAC to CMF on the basis of 10 yr. survival. How can they compare AC+T and and TAC to CMF on 10 yr. survival when, to my knowledge, AC+T and TAC haven't been around that long?
Dear Franciscus: You are correct that the clinical trials evaluating "AC+T" (Adriamycin and Cytoxan followed by Taxol) and "TAC" (Taxotere, Adriamycin and Cytoxan) are too recent to report 10 year results. In addition, neither of these regimens have been directly compared to "CMF" (cytoxan, methotrexate and 5-fluorouracil) but rather to other regimens that have been compared to CMF. It is, therefore, impossible to make direct comparisons of these regimens at 10 years. On the other hand, it is possible to estimate risk-reduction at 10 years using various statistical models and, indirectly, can get a sense of the approximate anticipated benefit of each of the regimens based on their performance at an earlier time period. The comparisons you have seen are likely using models to predict recurrence risk at 10 years based on the characteristics of the cancer and the relative benefit of the chemotherapy regimens as observed in clinical trials.
There is so much "noise" in the various chemotherapy treatment statistics, it makes it very difficult to base a chemotherapy treatment decision on those statistics. There is little else to base decisions on, apparently. I guess one has to get second and third opinions from trusted and experienced oncologists and go form there. Thanks.
I just read an article in from the last big oncology meeting, I think it was in Orlando. Anyway, they said they are finding that women who did Taxotere in addition to AC as opposed to just AC or AC with 5-Fu are 26% less likely to have a recurrence. I don't understand all this % stuff, but do think that is pretty significant. This was comparing the 2 over a 5 year period of time. Also, from what my oncologist told me taxotere maybe has only been on the market for 8-9 years (now)however, there are many clinical studies done on these drugs for several years before they are actually approved. I think orginally it was just given for met. bc.
This is just based on what I've been told and have read. I just thought you might like to hear anoter version. I think the bottom line is if given the choice you should add either taxotere or taxol to your chemo regimen.
Copyright 1994-2018MedHelp.All rights reserved. MedHelp is a division of Vitals Consumer Services, LLC.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. MedHelp is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.